细胞外信号调节激酶1/2通路在硫化氢补充对实验性青光眼神经保护作用中的参与不充分
本研究使用168只合格大鼠的青光眼模型,给予硫化氢供体硫氢化钠(NaHS)或ERK抑制剂PD98059处理,评估RGC存活与凋亡及相关通路活性。结果显示NaHS与PD98059均抑制ERK 1/2通路,但PD98059不影响RGC存活、凋亡调控或自噬,提示抑制ERK 1/2通路可能部分参与H2S的神经保护,但不足以单独启动治疗效应。
要点
- NaHS与PD98059在实验性青光眼大鼠视网膜中均抑制ERK 1/2通路活性。
- PD98059同样抑制胶质激活、NF-κB通路、NADPH氧化酶和TNF-α产生。
- PD98059不影响RGC存活、凋亡调控或自噬,与NaHS不同。
核心结论
- 抑制ERK 1/2通路可能部分参与H2S在实验性青光眼中的神经保护作用,但不足以单独启动治疗效应。
研究设计与样本
- 研究使用已建立的大鼠青光眼模型,168只合格大鼠接受硫氢化钠(NaHS,一种H2S供体)/PD98059(一种ERK抑制剂)处理。
- 通过逆行标记和TUNEL染色评估RGC存活与凋亡,并通过免疫组化、Western blotting和ELISA评估ERK 1/2通路、内源性凋亡通路、胶质激活、NF-κB通路、NADPH氧化酶、自噬和TNF-α产生的活性。
主要发现
- NaHS在实验性青光眼大鼠视网膜中抑制ERK 1/2通路活性,与PD98059相似。
- PD98059同样抑制胶质激活、NF-κB通路、NADPH氧化酶和TNF-α产生。
- PD98059不影响RGC存活、凋亡调控或自噬,而NaHS则影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Glaucoma is a neurodegenerative eye disease characterized by gradually impaired visual field and irreversible blindness due to retinal ganglion cell (RGC) loss. Our previous studies have confirmed that hydrogen sulfide (H2S) takes part in the glaucomatous process and contributes to RGC protection. The present study aimed to further investigate the role of extracellular signal-regulated kinase 1/2 (ERK 1/2) pathway underlying the impact of H2S, to better understand the mechanism through which H2S exerts neuroprotection in glaucoma. METHODS: An established rat glaucoma model was used and 168 rats were qualified to undergo sodium hydrosulfide (NaHS, a H2S donor)/PD98059 (an ERK inhibitor) treatment. Then the survival and apoptosis of RGC were evaluated through retrograde labeling and TUNEL staining, along with activity evaluations of ERK 1/2 pathway, intrinsic apoptotic pathway, glial activation, nuclear factor kappa B (NF-κB) pathway, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, autophagy, and TNF-α production through immunohistochemistry, Western blotting, and ELISA. RESULTS: The study demonstrated that NaHS suppressed ERK 1/2 pathway activity similarly to PD98059 in retinas of experimental glaucoma rats, while PD98059 also similarly suppressed glial activation, NF-κB pathway, NADPH oxidase, and TNF-α production. However, PD98059 did not affect RGC survival, apoptotic regulation, or autophagy as NaHS did. CONCLUSIONS: Our study indicated that inhibition of ERK 1/2 pathway might partly contribute to the neuroprotection by H2S in experimental glaucoma; however, it was insufficient to initiate the therapeutic effect on its own.
引用
- Huang S, Huang P, Yu H, et al. Extracellular Signal-Regulated Kinase 1/2 Pathway Is Insufficiently Involved in the Neuroprotective Effect by Hydrogen Sulfide Supplement in Experimental Glaucoma. Invest Ophthalmol Vis Sci. 2019. PMID: 31626691. doi:10.1167/iovs.19-27507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。